Active	Status	Sponsor type	Region	Phase	Filter
8 Active 4 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stähli, Barbara E
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation	Recruiting	4	3010	Europe	P2Y12 inhibitor, Aspirin, DOAC	Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited	Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor	09/26	12/26
NCT04859985: The SELUTION DeNovo Study	Active, not recruiting	N/A	3326	Europe, RoW	SELUTION SLR, DES	M.A. Med Alliance S.A.	Coronary Artery Disease	08/25	07/30
MINOCA, NCT05326828: Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With	Recruiting	N/A	60	Europe	CONFIRM Rx implantable cardiac rhythm monitor (Abbott), Systematic etiologic work-up for underlying causes of MINOCA	Insel Gruppe AG, University Hospital Bern, University Hospital, Zürich, Bangerter-Rhyner Stiftung, Abbott	MINOCA, Atrial Fibrillation	05/26	05/31